Dordaviprone

About

Therapy type: Targeted therapy

Therapy strategy: Protease activation

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
FDA (1) H3-3A p.K27M Diffuse Midline Glioma Dordaviprone